Financial reports
20-F
2023 FY
Annual report (foreign)
15 May 24
NT 20-F
Notice of late annual filing (foreign)
1 May 24
20-F
2022 FY
Annual report (foreign)
16 May 23
NT 20-F
Notice of late annual filing (foreign)
28 Apr 23
20-F
2021 FY
Annual report (foreign)
31 Mar 22
20-F
2020 FY
Annual report (foreign)
15 Apr 21
20-F
2019 FY
Annual report (foreign)
23 Apr 20
Current reports
6-K/A
Current report (foreign) (amended)
26 Sep 24
6-K
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
25 Sep 24
6-K
Current report (foreign)
19 Sep 24
6-K
Current report (foreign)
6 Sep 24
6-K
Current report (foreign)
19 Aug 24
6-K
CENTOGENE Receives Delisting Notice From Nasdaq
7 Aug 24
6-K
Current report (foreign)
1 Aug 24
6-K
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
20 Jun 24
6-K
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
31 May 24
6-K
Current report (foreign)
29 May 24
Registration and prospectus
424B4
Prospectus supplement with pricing info
10 Jul 20
F-1
Registration statement (foreign)
7 Jul 20
DRS
Draft registration statement
26 Jun 20
DRSLTR
Correspondence regarding draft registration statement
26 Jun 20
424B4
Prospectus supplement with pricing info
8 Nov 19
S-8
Registration of securities for employees
7 Nov 19
8-A12B
Registration of securities on exchange
4 Nov 19
F-1/A
Registration statement (foreign) (amended)
28 Oct 19
F-1
Registration statement (foreign)
11 Oct 19
DRSLTR
Correspondence regarding draft registration statement
28 Mar 19
Proxies
No filings
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
17 May 24
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
17 May 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
31 Mar 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
15 Apr 21
EFFECT
Notice of effectiveness
10 Jul 20
CORRESP
Correspondence with SEC
7 Jul 20
CORRESP
Correspondence with SEC
7 Jul 20
UPLOAD
Letter from SEC
30 Jun 20
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
23 Apr 20
EFFECT
Notice of effectiveness
7 Nov 19
Ownership
SC 13D/A
TVM Life Science Innovation I L.P.
11 Mar 22
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
22 Feb 22
SC 13G
PLATINUM INVESTMENT MANAGEMENT LTD
9 Dec 21
144
Notice of proposed sale of securities
12 Jul 21
144
Notice of proposed sale of securities
7 Jul 21
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
12 May 21
SC 13G/A
Rolfs Arndt
16 Feb 21
144
Notice of proposed sale of securities
27 Jan 21
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
5 Nov 20
SC 13D/A
TVM Life Science Innovation I L.P.
3 Nov 20